Home Current Issue Previous Issues Epub Ahead Reports CME Podcasts Grand Rounds For Authors Journal Info
Skip Navigation LinksHome > January 2011 - Volume 70 - Issue 1 > Hemostatic Effects of Fresh Frozen Plasma May be Maximal at...
Journal of Trauma-Injury Infection & Critical Care:
doi: 10.1097/TA.0b013e318202e486
Original Article

Hemostatic Effects of Fresh Frozen Plasma May be Maximal at Red Cell Ratios of 1:2

Davenport, Ross BSc, MD, MRCS; Curry, Nicola MD, MRCP; Manson, Joanna MD, MRCS; De'Ath, Henry MD, MRCS; Coates, Amy BSc; Rourke, Claire BSc; Pearse, Rupert MD, FRCA; Stanworth, Simon MD, MRCP; Brohi, Karim MD, FRCA, FRCS

Collapse Box

Abstract

Background: Damage control resuscitation targets acute traumatic coagulopathy with the early administration of high-dose fresh frozen plasma (FFP). FFP is administered empirically and as a ratio with the number of packed red blood cells (PRBC). There is controversy over the optimal FFP:PRBC ratio with respect to outcomes, and their hemostatic effects have not been studied. We report preliminary findings on the effects of different FFP:PRBC ratios on coagulation.

Methods: This is a prospective observational cohort study of trauma patients requiring >4 U of PRBCs. Blood was drawn before and after each 4-U PRBC interval for prothrombin time and analysis by rotational thromboelastometry. Interval change in coagulation parameters were compared with the FFP:PRBC ratio received during each interval.

Results: Sixty 4-U PRBC intervals from 50 patients were available for analysis. All measures of coagulation deteriorated with low FFP:PRBC ratios (<1:2). Maximal hemostatic effect was observed in the 1:2 to 3:4 group: 12% decrease in prothrombin time (p = 0.006), 56% decrease in clotting time (p = 0.047), and 38% increase in maximum clot firmness (p = 0.024). Transfusion with ≥1:1 ratio did not confer any additional improvement. There was a marked variability in response to FFP, and hemostatic function deteriorated in some patients exposed to 1:1 ratios. The beneficial effects of plasma were confined to patients with coagulopathy.

Conclusions: Interim results from this prospective study suggest that FFP:PRBC ratios of ≥1:1 do not confer any additional advantage over ratios of 1:2 to 3:4. Hemostatic benefits of plasma therapy are limited to patients with coagulopathy.

© 2011 Lippincott Williams & Wilkins, Inc.

Follow Us


Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Readers Of this Article Also Read